Learn about the cardiovascular complications associated with type 2 diabetes, how cardiovascular safety became a focus in the management of type 2 diabetes, and more, with Drs. Eden Miller and James O'Keefe.

This is part 1 of a 3-part podcast series.

Copyright © 2021 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.
SC-US-69642-C (06/2021)

To get a better understanding of the impact of cardiovascular disease on patients with type 2 diabetes, join Drs. Eden Miller and James O'Keefe as they discuss how concurrent diabetes and cardiovascular disease can significantly affect life expectancy.

This is part 3 of a 3-part podcast series. Please listen to podcasts 1 and 2 before listening to this podcast.

Copyright © 2021 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.
SC-US-69642-E (06/2021)

Not only is hepatocellular carcinoma (HCC) the most common primary liver cancer in adults, but it’s also the fastest-growing cause of cancer-related deaths in the US. That’s why Dr. Joel Wedd, Associate Professor of Medicine at the Virginia Commonwealth University and Medical Director of Liver Transplant at the Hume-Lee Transplant Center, is here to discuss the pathogenesis of hepatocellular carcinoma, risk factors, the importance of early-stage detection, and more.

Metabolic dysfunction is the central driver for conditions with some of the highest mortality rates. Identifying this dysfunction early on is essential to preventing disease progression. Dr. Brett Nowlan, a cardiologist at Cottage Grove Cardiology in West Hartford, Connecticut, explains why.

Here to talk about some of the cellular changes associated with aging, how these changes manifest clinically as we age, and emerging nutritional interventions to target these changes is Dr. Eric Verdin, the President and Chief Executive Officer of the Buck Institute for Research on Aging.

With migraine as a major global health problem that affects over 10% of the population, approximately 1 billion globally, and about 12% in the US, now more than ever it’s vital that healthcare professionals have a deep understanding of the role of the calcitonin gene-related peptide (CGRP) and its receptor in migraine pathophysiology1,2,3. That’s why Dr. Merle Lea Diamond joins Dr. Jerome Lisk to review that and more.

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2018;392:1789-1858.
2. Lipton RB, et al. Neurology. 2007;68:343-349.
3. Lassen LH, et al. Cephalalgia. 2002;22:54-61.

USA-334-84583

With more patients opting for home-based care over long-term, acute, and office-based care, it’s important that we align with our patients on what’s most important to them and how they want to be cared for, especially those who are nearing the end of life.

That’s why VITAS Medical Director, Dr. Andy Arwari, is here to share the purpose of goals-of-care conversations and how an app can aid in determining if an advanced illness patient is eligible for hospice.

Real-world effectiveness of influenza vaccines vary from year to year based on several factors. But how is real-world effectiveness measured? And what roles do the data gathered from real-world clinical trials play in estimating vaccine effectiveness? Here to answer that and other practical questions are Dr. Stephen Pelton, Professor of Pediatrics and Epidemiology at the Boston University School of Medicine and Public Health and Dr. L.J. Tan, Chief Strategy Officer for the Immunization Action Coalition and Co-Founder of the National Adult and Influenza Immunization Summit.

USA-CRP-21-0009 May 2021

Egg-based manufacturing methods for influenza vaccines have been a mainstay of production. But the recent emergence of a cell based manufacturing method changes our approach entirely. What will this paradigm shift look like? Are there new opportunities and challenges to address along the way? Here to answer that and other practical questions is Dr. Lauren Angelo, Associate Dean for Academic Affairs and an Associate Professor of Pharmacy Practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.

USA-CRP-21-0030 May 2021

When dermatologists and psoriasis patients fail to align on treatment expectations, this can lead to missed opportunities in achieving higher levels of skin clearance. Fortunately, utilizing certain therapeutic and counseling strategies can help dermatologists better align with their patients and improve their standards of care. Joining Dr. Matt Birnholz to share these practical strategies are Drs. April Armstrong and Laura Ferris.

VERSION 1.0 | MAY 2021 | ABBV-US-00466-MC